mobile internet-based remote home rehabilitation improves prognostic function and life quality in pulmonary hypertension

Conditions: Pulmonary Hypertension

Summary: the goal of this clinical trial is to learn the effectiveness of remote home-based exercise rehabilitation using mobile internet technology for patients with pulmonary hypertension，especically providing early and mid-term results of its effectiveness. the main questions it aims to answer are: dose tele-rehabilitation training improves prognostic function and quality of life in patients with pulmonary hypertension？ researchers will compare tele-rehabilitation training group to a control group (receive health propaganda and education, and then follow their daily routine after discharge from the hospital) to see if tele-rehabilitation training works to improve prognosis. participants will: during their stay in the hospital, the patients of tele-rehabilitation training group were accompanied by a rehabilitation trainer and a psychotherapist for a complete cycle of (7 days ± 3 days 1 week/times) standardized training. the scheme of rehabilitation is impedance training. a specialized professional team including cardiologists, rehabilitation trainers, psychotherapists and radiologists were involved. after discharge from the hospital, patients in the rehabilitation group underwent 3-5 weekly daily training sessions and intensive supervision and management by the online community at least once a week. visit the clinic at the 3rd month of the study. extended follow-up up to 6 months may be considered if patients are cooperative and could complete the training program in the first 3 months.


Eligibility criteria:
inclusion criteria: * 1. age 18- 60 years old; * 2. ph were defined as: mpap \> 20 mmhg, pawp ≦ 15 mmhg and pvr \> 2 wu measured by right heart catheterization at sea level at rest; * 3. arterial pulmonary hypertension (pah), pulmonary hypertension associated with lung diseaseor and chronic thromboembolic pulmonary hypertension (cteph) according to the who ph classification; * 4. no syncope or syncopal aura during walking or recovery. * 5. no serious arrhythmia caused by rest or exercise such as ventricular tachycardia, ventricular fibrillation, class iii atrioventricular block, etc. * 6. stable medication and medication regimen for at least 3 months prior to randomization and no organized exercise training of any kind for at least 3 months prior to screening * 7. be proficient in the use of smartphones and monitoring devices; * 8. sign an informed consent form. exclusion criteria: * 1. combined with vte. * 2. acute pulmonary embolism. * 3. low-intensity exercise (\<3mets) or angina pectoris symptoms/signs during the recovery period. * 4. hemodynamic abnormality during exercise (especially systolic blood pressure doesn't rise or fall or arrhythmia occurs when the exercise load is increased). * 5. severe psycho-cognitive disorders. * 6. couldent do exercise due to the neurological or musculoskeletal dysfunction. * 7. patients with cteph who are scheduled to undergo percutaneous pulmonary artery balloon dilatation or pulmonary artery endarterectomy within 6 months. * 8. patients with a combination of other consumptive underlying diseases, such as malignant tumors, pulmonary tuberculosis, hyperthyroidism, severe depression, etc. * 9. pregnancy. * 10. refused to sign the informed consent form.